180 likes | 575 Views
GLYCOGEN BREAKDOWN. PHOSPHORYLASE. (GLUCOSE)n + Pi (GLUCOSE)n-1 + G-1-P. PHOSPHOROLYSIS OF a (1-4)LINKAGES UP TO 4 GLUCOSE RESIDUES FROM AN a (1-6)BRANCH POINT. GLYCOGEN SYNTHESIS. HEXOKINASE. GLUCOSE + ATP GLUCOSE-6-PHOSPHATE + ADP. PHOSPHOGLUCOMUTASE.
E N D
GLYCOGEN BREAKDOWN PHOSPHORYLASE (GLUCOSE)n + Pi (GLUCOSE)n-1 + G-1-P PHOSPHOROLYSIS OF a(1-4)LINKAGES UP TO 4 GLUCOSE RESIDUES FROM AN a(1-6)BRANCH POINT
GLYCOGEN SYNTHESIS HEXOKINASE GLUCOSE + ATP GLUCOSE-6-PHOSPHATE + ADP PHOSPHOGLUCOMUTASE GLUCOSE-6-PHOSPHATE GLUCOSE-1-PHOSPHATE GLUCOSE-1-PHOSPHATE URIDYLTRANSFERASE GLUCOSE-1-PHOSPHATE + UTP UDP-GLUCOSE + PPi GLYCOGEN SYNTHASE UDP-GLUCOSE + GLYCOGEN (n) GLYCOGEN(n+1) + UDP
PHOSPHORYLASE Tower Allosteric effector site N-terminal domain (Glycogen-binding subdomain) N-terminal domain (Interface subdomain) Glycogen Storage site Catalytic site C-terminal domain Pyridoxal phosphate site T conformation (Inactive- Buried active site) R conformation (Active – Accessible Active Site) Stabilized by:AMP Pi Phosphorylation Stabilized by:ATP G-6-P Glucose (Liver)
Pi Pi Pi Pi PHOSPHORYLASE REGULATION PHOSPHORYLASE b KINASE 2ADP 2ATP T FORM T FORM (INACTIVE) (INACTIVE) 2Pi 2H20 SERINE 14 N-TERMINUS (AMP-INDEPENDENT) PROTEIN PHOSPHATASE ATP and/or G-6-P Glucose (Liver) AMP R FORM R FORM (ACTIVE) (ACTIVE) PHOSPHORYLASE a PHOSPHORYLASE b
PHOSPHORYLASE REGULATION BY PHOSPHORYLATION 4ADP 4ATP Ca2+ PHOS a –TETRAMER PHOSPHORYLASE b KINASE 2(PHOS b) DIMER PROTEIN PHOSPHATASE-1 AMP INDEPENDENT P ACTIVATORS:AMP, Pi INHIBITORS:ATP, G-6-P AMP INHIBITS 4Pi GLYCOGEN(n) GLYCOGEN(n-1) + G-1-P
STRUCTURE OF PHOSPHORYLASE KINASE REGULATORY SUBUNITS b b a a ACTIVE SITE d d g g g g CALCIUM-BINDING PROTEIN (CALMODULIN) d d a a b b • ENTIRELY IN b FORM IN RESTING • MUSCLE • ACTIVATED BY: • (i) INCREASED Ca 2+ • - CONTRACTION • - a1-ADRENERGIC AGENTS • - ANGIOTENSIN • - VASOPRESSIN • PHOSPHORYLATION • - cAMP-DEPENDENT PROTEIN • KINASE
PHOSPHORYLASE KINASE REGULATION Ca2+ PHOSPHORYLATED KINASE Ca2+-FREE KINASE Ca2+-KINASE PARTIALLY ACTIVE FULLY ACTIVE Reduced Ca2+ Requirement (a form) 15-20-fold activity Ca 2+ sensitivity 20mM to 1mM INACTIVE Requires Ca2+ bound to d subunit (b form) cAMP-DEPENDENT PROTEIN KINASE ATP ADP PHOSPHORYLASE b KINASE a (FULLY ACTIVE) PHOSPHORYLASE b KINASE b (LESS ACTIVE) Pi PROTEIN PHOSPHATASE -1 cAMPPK
PI-1 PI-1 PI-1 GBS GBS P P P P PP1 PP1 PP1 DEPHOSPHORYLATION OF PHOSPHORYLASE AND PHOSPHORYLASE KINASE PROTEIN PHOSPHATASE 1 95% ACTIVITY TOWARDS PHOSPHORYLASE 95% ACTIVITY TOWARDS b-SUBUNIT OF PHOSPHORYLASE KINASE 85% ACTIVITY TOWARDS GLYCOGEN SYNTHASE (Sites 1a, 2, 3(a,b,c)) TIGHT COMBINATION WITH GLYCOGEN VIA GLYCOGEN BINDING SUBUNIT. RELEASED ON PHOSPHORYLATION BY cAMPPK (SITES 1 & 2) INHIBITED BY PROTEIN PHOSPHATASE 1 INHIHIBITOR (PI-1) WHEN PI-1 ACTIVATED BY PHOSPHORYLATION BY cAMPPK. GLYCOGEN GLYCOGEN INACTIVE + ACTIVE ACTIVE INACTIVE
PROTEIN PHOSPHATASES TYPE 2 INSENSITIVE TO INHIBITOR PROTEINS. PREFERENTIALLY DEPHOSPHORYLATES a-SUBUNIT OF PHOSPHORYLASE KINASE. TYPE 2A (PP-2A) 36kDa C SUBUNIT, 60kDa A SUBUNIT, 54kDa B SUBUNIT. ACCOUNTS FOR AN APPRECIABLE AMOUNT OF GLYCOGEN SYNTHASE ACTIVITY AND A SMALL AMOUNT OF PHOSPHORYLASE AND PHOSPHORYLASE KINASE ACTIVITY. MAJOR PHOSPHORYLASE KINASE a-SUBUNIT AND PI-1 PHOSPHATASE IN ABSENCE Ca2+. TYPE 2C (PP-2C) DIMER OF 44kDa SUBUNIT. NO ACTIVITY TOWARDS ENZYMES OF GLYCOGEN METABOLISM. TYPE 2B (PP-2B) CONSISTS OF A SUBUNIT (CATALYTIC) AND B SUBUNIT (CALCIUM BINDING). DEPHOSPHORYLATES INHIBITOR-1 AND REGULATORY SUBUNIT OF PKA, a-SUBUNIT OF PHOSPHORYLASE KINASE AND MYOSIN LIGHT CHAIN KINASE. BINDS TO CALMODULIN TO INCREASE ACTIVITY 10-FOLD. INCREASES Vmax. LITTLE ACTIVITY TOWARDS METABOLIC ENZYMES. MAY BE MAJOR PHOSPHATASE DURING CONTRACTION
+G-6-P Glucose Pi PHOSPHATASE GLYCOGEN SYNTHASE D GLYCOGEN SYNTHASE I Less Active Active KINASE ATP ADP TETRAMER Activated by G-6-P Inhibited by ATP, Pi, UDP CONTROL OF GLYCOGEN SYNTHASE NINE PHOSPHORYLATION SITES (SERINE RESIDUES) - SITES 2 AT THE N TERMINUS, REMAINDER AT C TERMINUS. REQUIRE PHOSPHORYLATION AT BOTH N AND C TERMINUS FOR INACTIVATION.
GLYCOGEN SYNTHASE PHOSPHORYLATION CAMPPK 1A > 2 > 1B PHOSPHORYLASE KINASE (Ca2+) 2 GSK 3 3A, 3B, 3C GSK4 2 GSK5 5 CAM DEPENDENT PK (Ca 2+) 2 PHOSPHORYLATION INCREASES THE KM FOR UDP-GLUCOSE. INCREASES KA FOR G-6-P AND DECREASES KI FOR PI. MOST STRONGLY INACTIVATING SITES - 3A,B,C > 2 > 1 EFFECTS ARE ADDITIVE ACTIVITY IN RESPONSE TO (I) ADRENALINE (II) GLYCOGEN CONTENT OF MUSCLE ACTIVITY IN RESPONSE TO (I) INSULIN (II) GLYCOGEN CONTENT OF MUSCLE IN FED ANIMAL ACTIVITY LOW AND ENZYME PHOSPHORYLATED CF. PHOSPHORYLASE KINASE AND PHOSPHORYLASE, ACTIVITY LOW AND DEPHOSPHORYLATED - cAMP LOW AND THEREFORE NOT cAMPPK. GSK-3 THE MAJOR KINASE
CONTROL OF GLYCOGEN SYNTHASE BY ADRENALINE AND INSULIN ADRENALINE INHIBITS GLYCOGEN SYNTHASE BY cAMP DEPENDENT MECHANISM ADRENALINE PROPRANOLOL ACTIVITY 20% 100% PHOSPHATE 5MOLES/SUBUNIT 3MOLES/SUBUNIT 50% OF Pi IN SITES 3a,b,c. 50% IN SITES 1a, 1b, AND 2. 75% DECREASE IN ACTIVITY RESULTS FROM SITES 3a,b,c. CATALYSED BY GSK-3 WHICH IS cAMP-INDEPENDENT, THEREFORE MAJOR INACTIVATING EFFECT IS DUE TO INHIBITION OF PHOSPHATASE RATHER THAN ACTIVATION OF KINASE INSULIN TREATMENT REDUCES Pi BY 0.5 MOLES Pi/SUBUNIT FROM SITES 3a,b,c (NOT CAMP MEDIATED) THEREFORE EITHER IT INHIBITS GSK3 OR ACTIVATES PHOSPHATASE ALSO GLUCOSE TRANSPORT (GLUT4) AND G-6-P
R2 C2 (Inactive) PP1G P P P P P P (Active) PhK (Less Active) GS (Active) CONTROL OF GLYCOGEN METABOLISM BY cAMP ADRENALINE GLUCAGON (Muscle) (Liver) b-RECEPTOR RECEPTOR ATP cAMP 2C + R2 (cAMP)4 PI-1 (Active) PP2A PI-1 PPI- PI-1 PP1 + G PhK PP2A Sites 1 & 2 (More Active) Sites 1a, 2,1b (Inactive) Site 2 GS (Less Active) Phosa Phos b X (Active) (Inactive)
CONTROL OF GLYCOGEN SYNTHASE BY INSULIN GLUCOSE INSULIN GLUT4 RECEPTOR Glucose IRS-1, SHC Grb2/mSOS RAS PI-3K G-6-P RAF PKB MEK GSK3 MAP KINASE (Inactive) C p90rsk PP1G Site 1 + (More active) Other pathways ? N GLYCOGEN SYNTHASE = (ISPK, MAPKAK-1) p90rsk The relative importance of these pathways may vary from tissue to tissue
PP1G P P P P P P (Active) CONTROL OF GLYCOGEN METABOLISM BY INSULIN GLUCOSE INSULIN Receptor Glut4 TYROSINE KINASE GSK-3 GLUCOSE PKB MAPK (Active) (Active) G-6-P ISPK (p90rsk) ISPK GSK-3 (Active) (Inactive) PHOSPHORYLASE GLYCOGEN SYNTHASE PP1G (More Active) GS Site1 (Less Active) X PHOSKa (More Active) GS (More Active) PHOSKb ADRENALINE PPIG –SITES 1 & 2 PHOSa PHOSb (Less Active) (Active) (Inactive)
GLYCOGEN METABOLISM IN LIVER MANY EFFECTS THROUGH Ca2+ RATHER THAN cAMP VIA ADRENALINE (1), ANGIOTENSIN II AND VASOPRESSIN. PHOSPHORYLASE – DIFFERENT ISOENZYME FROM MUSCLE. NOT CONTROLLED BY AMP OR G-6-P. GLUCOSE BINDS TO ACTIVE SITE AND COMPETITIVELY INHIBITS THE ENZYME AND MAKES MORE SUSCEPTIBLE TO DEPHOSPHORYLATION GLYCOGEN SYNTHASE - PHOSPHORYLATION DECREASES Vmax RATHER THAN INCREASING Km FOR UDPG. NO SITES 1a AND 1b. GLUCAGON AND GLUCOSE MAIN EFFECTORS. G-6-P PROMOTES DEPHOSPHORYLATION BY PP1 AS WELL AS ALLOSTERICALLY ACTIVATING. PP1-G – GLYCOGEN BINDING SUBUNIT SMALLER AND NO EVIDENCE FOR CONTROL BY PHOSPHORYLATION. G SUBUNITS ANCHOR PHOSPHATASE TO GLYCOGEN PARTICLES AND DECREASES SENSITIVITY TO PI-1. BINDS STRONGLY TO PHOSa BUT NOT PHOSb
GLYCOGEN METABOLISM IN LIVER 11 GLUCAGON – INCREASES cAMP LEADING TO INCREASED PHOS KINASE AND PHOSa ACTIVITY. PHOSa ACTS AS ALLOSTERIC INHIBITOR TO INHIBIT PPI-G AND PREVENT DEPHOSPHORYLATION. SIMILAR EFFECTS OCCUR WITH ADRENALINE VIA INCREASED Ca2+ AND PHOS KINASE. BOTH PHOSPHORYLATE GLYCOGEN SYNTHASE VIA cAMPPK AND Ca2+/CALMODULIN DEPENDENT PROTEIN KINASES. INSULIN – ACTIVATES cAMP-PDE VIA PI-3-KINASE PATHWAY LEADING TO DECREASE IN cAMP AND REDUCTION IN PHOS KINASE AND PHOSa AND DECREASE IN GLYCOGENOLYSIS. ALSO ATTENUATES THE ALLOSTERIC INHIBITION OF PPI-G CAUSING RELEASE OF PP1-G AND DEPHOSPHORYLATION OF GLYCOGEN SYNTHASE AND PHOSPHORYLASE KINASE. EFFECT OF GLUCOSE – ENHANCES GLYCOGEN DEPOSITION. PHOSa FUNCTIONS AS GLUCOSE RECEPTOR. BINDS TO ACTIVE SITE AND COMPETITIVELY INHIBITS THE ENZYME. ALSO INDUCES CONFORMATIONAL CHANGE (STABILISES THE T STATE) CAUSING SER 14 TO BECOME ACCESSIBLE TO PP1-G LEADING TO DEPHOSPHORYLATION. CAUSES RELEASE OF PP1-G ALLOWING IT TO INTERACT WITH GLYCOGEN SYNTHASE SWITCHING IT ON.